Investments in Non-Marketable Securities - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jul. 31, 2021	Nov. 30, 2020
Marketable Securities [Line Items]
Investment in non-marketable debt security	$ 0	$ 1,000,000		$ 1,000,000
Conversion, debt to equity			$ 1,300,000
Interest income from amortization of discount	300,000
Upward price adjustment, annual amount	0	0
Downward price adjustment, annual amount	0	0
Investment in non-marketable equity securities ($12,713 and $1,450 with a related party)	14,002,000	1,450,000
Other Nonoperating Income (Expense)
Marketable Securities [Line Items]
Upward price adjustment, annual amount	1,000,000
Molecular Assemblies, Inc.
Marketable Securities [Line Items]
Investment in non-marketable equity securities ($12,713 and $1,450 with a related party)	12,700,000	$ 1,500,000
Arzeda Corp.
Marketable Securities [Line Items]
Investment in non-marketable equity securities ($12,713 and $1,450 with a related party)	$ 1,300,000
Series B-2 Preferred Stock
Marketable Securities [Line Items]
Debt conversion, shares issued (in shares)	207,070
Convertible Debt
Marketable Securities [Line Items]
Investment in non-marketable debt security	$ 0